艾司奥美拉唑与生长抑素单个静脉通道持续泵入体外配伍禁忌研究及相关文献分析

庞国勋; 闫彬; 靳会欣; 王志恒

doi:10.14009/j.issn.1672-2124.2022.11.007

您当前的位置：

首页 >

文章列表页 >

艾司奥美拉唑与生长抑素单个静脉通道持续泵入体外配伍禁忌研究及相关文献分析

论著 | 更新时间：2023-04-16

- 艾司奥美拉唑与生长抑素单个静脉通道持续泵入体外配伍禁忌研究及相关文献分析
- Extracorporal Incompatibility of Esomeprazole with Single Intravenous Access Continuous Pumping of Somatostatin and Literature Review
- 中国医院用药评价与分析 2022年第11期页码：1315-1317
- 作者机构：
  
  河北省人民医院药学部
- 作者简介：
- 基金信息：
  
  2022年度河北省医学科学研究课题（No.20220054）
- DOI：10.14009/j.issn.1672-2124.2022.11.007
  中图分类号： R969.3
- 纸质出版日期：2022，
扫描看全文
庞国勋, 闫彬, 靳会欣, 等. 艾司奥美拉唑与生长抑素单个静脉通道持续泵入体外配伍禁忌研究及相关文献分析[J]. 中国医院用药评价与分析, 2022,(11):1315-1317.

PANG Guoxun, YAN Bin, JIN Huixin, et al. Extracorporal Incompatibility of Esomeprazole with Single Intravenous Access Continuous Pumping of Somatostatin and Literature Review[J]. 2022,(11):1315-1317.
庞国勋, 闫彬, 靳会欣, 等. 艾司奥美拉唑与生长抑素单个静脉通道持续泵入体外配伍禁忌研究及相关文献分析[J]. 中国医院用药评价与分析, 2022,(11):1315-1317. DOI： 10.14009/j.issn.1672-2124.2022.11.007.

PANG Guoxun, YAN Bin, JIN Huixin, et al. Extracorporal Incompatibility of Esomeprazole with Single Intravenous Access Continuous Pumping of Somatostatin and Literature Review[J]. 2022,(11):1315-1317. DOI： 10.14009/j.issn.1672-2124.2022.11.007.

摘要

目的：完善艾司奥美拉唑与生长抑素配伍使用的稳定性资料，为临床合理用药提供理论支撑。方法：检索中国知网、万方数据库和PubMed等数据库，汇总艾司奥美拉唑和生长抑素配伍使用稳定性的相关文献；并基于临床应用的真实场景，进行两种药物配伍使用的基础实验研究。结果：共纳入与两种药物体外配伍相关的文献7篇，提示艾司奥美拉唑与生长抑素等多种药物配伍可发生颜色变化或产生沉淀；基础实验灯检结果显示，配伍液1 h出现结晶，4 h出现肉眼可见微粒。结论：艾司奥美拉唑与生长抑素的pH相差较大，存在配伍禁忌，为保证静脉用药安全，不宜共用单个静脉通道持续泵入，建议分开单独使用，或与其他药物共用静脉通道。

Abstract

OBJECTIVE: To improve the stability data for the compatibility of esomeprazole with somatostatin

so as to provide theoretical support for the rational clinical application. METHODS: Literature related to the stability of compatibility of esomeprazole with somatostatin were retrieved from CNKI

Wanfang Data and PubMed. The basic experimental study on the compatibility of two drugs was conducted based on the real scenario of clinical application. RESULTS: A total of 7 papers related to the extracorporal compatibility of the two drugs were enrolled

which suggested that color change or precipitation can occur in the compatibility of esomeprazole with somatostatin and other drugs. Results of basic experimental light inspection showed that crystals appeared in the compatibility solution at 1 h and the particles were visible to naked eye at 4 h. CONCLUSIONS: The difference of pH between esomeprazole and somatostatin is large

so that there are incompatibilities. To ensure the safety of intravenous drug administration

it is not advisable to share a single intravenous access for continuous pumping

and it is recommended to apply separately or share the intravenous access with other drugs.

关键词

艾司奥美拉唑生长抑素配伍禁忌持续泵入静脉通道

Keywords

EsomeprazoleSomatostatinIncompatibilityContinuous pumpingIntravenous access

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

多种微量元素注射液相关药品不良反应及联合用药中配伍禁忌分析与预防策略

三种质子泵抑制剂治疗应激性溃疡出血的网状Meta分析

艾司奥美拉唑与奥美拉唑治疗十二指肠溃疡的系统评价